Enhancement of sensitivity to cisplatin by orobol is associatedwith increased mitochondrial cytochrome c releasein human ovarian carcinoma cells

By Isonishi S.   Saitou M.   Yasuda M.   Ochiai K.   Tanaka T.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 413-420

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAIL-encoding retrovirus

By                      

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1254-1258

Spandidos Publications

Access to resources Recommend Favorite

The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 389-394

Spandidos Publications

Access to resources Recommend Favorite

Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells

By Chen Jianli   Adikari Mahesha   Pallai Rajash   Parekh Hemant   Simpkins Henry  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK

By              

International Journal of Oncology, Vol. 43, Iss. 3, 2013-01 ,pp. : 721-728

Spandidos Publications

Access to resources Recommend Favorite